Richard A Michaels

US Patent:

20020156651, Oct 24, 2002

Filed:

Apr 18, 2001

Appl. No.:

09/837490

Inventors:

Vito Florio - Coral Springs FL, US
Richard Michaels - Largo FL, US

International Classification:

G06F017/60

US Classification:

705/002000

Abstract:

A system and method for coordinated evaluation and prescription of unregulated therapeutic substances in a supervised medical environment, wherein the unregulated therapeutic substances, derived from natural products, are initially qualified as a therapeutic option to traditional prescription and OTC medicines. The implementation of the system and method of qualification and prescription of unregulated therapeutic substances is performed within the context of a mainstream medical care environment comprising an established health care management system wherein patient subscribers, within a given system, elect to participate in a trial evaluation under the supervision of the medical professional responsible for their care. Upon successful completion of the evaluation, the patient is empowered, with his medical professional's approval, to adopt the unregulated therapeutic substances for treatment of his illness or condition, and the established health care management system is obligated to reimburse such patient for such unregulated therapeutic substances.

US Patent:

20020156653, Oct 24, 2002

Filed:

Sep 18, 2001

Appl. No.:

09/955598

Inventors:

Vito Florio - Coral Springs FL, US
Richard Michaels - Largo FL, US

Assignee:

National Health Essentials, Inc.

International Classification:

G06F017/60

US Classification:

705/003000

Abstract:

A natural health integrated medical program and method for coordinated prescription of unregulated therapeutic substances in a supervised medical environment, wherein the unregulated therapeutic substances, derived from natural products, are initially documented and qualified as a therapeutic option to traditional prescription and over-the-counter medicines. The implementation of the program and method of qualification and prescription of unregulated therapeutic substances is performed within the context of a mainstream medical care environment comprising a Medical Care Entity, wherein patients within a given system, elect to participate in the program under the supervision of the medical professional responsible for their care. Upon initial successful completion of the program, the patient is empowered, with the medical professional's approval, to adopt the unregulated therapeutic substances for treatment of his/her illness or condition.